Multiple Sclerosis Lesions
Links shared publicly online about this topic
Teaching NeuroImages: Marked reduced apparent diffusion coefficient in acute multiple sclerosis lesion --" Neurology
neurology.org — “Teaching NeuroImages: Marked reduced apparent diffusion coefficient in acute multiple sclerosis lesion --" Neurology” View full resource at neurology.org
Most Recently Shared on May 24, 2010 at 3:06 pm By:
Neurology Journal Medical Journal and Neurology
#AAN- Teaching NeuroImages: Marked reduced apparent diffusion coefficient in acute multiple sclerosis lesion http://bit.ly/9m0e5Q
The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PD-L1 levels on CNS cells - Pittet - 2011 - Glia - Wiley Online Library
onlinelibrary.wiley.com — “The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PD-L1 levels on CNS cells - Pittet - 2011 - Glia - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 2, 2011 at 2:54 am By:
The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PDâ€*L1 ... http://bit.ly/e3y4gu
Teaching NeuroImages: Marked reduced apparent diffusion coefficient in acute multiple sclerosis lesion -- Bugnicourt et al. 74 (20): e87 -- Neurology
neurology.org — “Teaching NeuroImages: Marked reduced apparent diffusion coefficient in acute multiple sclerosis lesion -- Bugnicourt et al. 74 (20): e87 -- Neurology” View full resource at neurology.org
Most Recently Shared on May 18, 2010 at 5:27 pm By:
Teaching NeuroImages: Marked reduced apparent diffusion coefficient in acute multiple sclerosis lesion: (Source: N... http://bit.ly/9By8tA
The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PD-L1 levels on CNS cells - Pittet - 2011 - Glia - Wiley Online Library
onlinelibrary.wiley.com — “The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PD-L1 levels on CNS cells - Pittet - 2011 - Glia - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 2, 2011 at 4:29 am By:
The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PDâ€*L1 ... http://bit.ly/e3y4gu
Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood–brain barrier permeability measurement in enhancing multiple sclerosis lesions - Jelescu - 2011 - Journal of Magnetic Resonance Imaging - Wiley Online Library
onlinelibrary.wiley.com — “Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood–brain barrier permeability measurement in enhancing multiple sclerosis lesions - Jelescu - 2011 - Journal of Magnetic Resonance Imaging - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on May 20, 2011 at 2:57 am By:
Dualâ€*temporal resolution dynamic contrastâ€*enhanced MRI protocol for blood–brain barrier permeability measu... http://bit.ly/iGIXZC
Cortical lesions in children with multiple sclerosis
neurology.org — “Cortical lesions in children with multiple sclerosis” View full resource at neurology.org
Most Recently Shared on March 10, 2011 at 4:45 pm By:
Neurology Journal Medical Journal and Neurology
Cortical lesions in children with multiple sclerosis http://bit.ly/eibSjK #neurology
Actelion drug cuts brain lesions in MS patients
health.yahoo.net — “Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.” View full resource at health.yahoo.net
Most Recently Shared on August 2, 2011 at 9:40 am By:
Actelion drug cuts brain lesions in MS patients http://bit.ly/quxJeX
Actelion drug cuts brain lesions in MS patients | Reuters
reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy ride” View full resource at reuters.com
Most Recently Shared on August 2, 2011 at 11:00 am By:
Drug cuts brain lesions in MS patients: Actelion study http://reut.rs/qTZCcT
Actelion drug cuts brain lesions in MS patients
health.yahoo.net — “Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.” View full resource at health.yahoo.net
Most Recently Shared on August 2, 2011 at 9:58 am By:
Jennifer Ann Grisso Nurse and Active Health Library
Actelion drug cuts brain lesions in MS patients: Actelion's experimental multiple sclerosis drug ponesimod met i... http://bit.ly/nTUdDA
Actelion drug cuts brain lesions in MS patients
health.yahoo.net — “Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.” View full resource at health.yahoo.net
Most Recently Shared on August 2, 2011 at 9:42 am By:
Jane Anderson Healthy Eating Advisor
Actelion drug cuts brain lesions in MS patients http://bit.ly/qrxENz
Actelion drug cuts brain lesions in MS patients | Reuters
reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy ride” View full resource at reuters.com
Most Recently Shared on August 2, 2011 at 5:53 am By:
RT @MedicalNews Drug cuts brain lesions in MS patients: Actelion study http://bit.ly/re6iDO
Actelion drug cuts brain lesions in MS patients | Reuters
reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy ride” View full resource at reuters.com
Most Recently Shared on August 2, 2011 at 7:54 am By:
Drug cuts brain lesions in MS patients: Actelion study: ZURICH (Reuters) - Swiss biotech company A... http://bit.ly/nxrPjY #health #news
Actelion drug cuts brain lesions in MS patients | Reuters
reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy ride” View full resource at reuters.com
Most Recently Shared on August 2, 2011 at 6:18 am By:
Drug cuts brain lesions in MS patients: Actelion study: ZURICH (Reuters) - Swiss biotech… http://goo.gl/fb/nG3rE
Actelion drug cuts brain lesions in MS patients | Reuters
reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy ride” View full resource at reuters.com
Most Recently Shared on August 2, 2011 at 11:09 am By:
RT @MaureenFierce: Actelion's experimental multiple sclerosis drug ponesimod met main goal in Phase II trial. http://reut.rs/odFNOF
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Neurology Journal
-
Neurology OW
Organizing neurology resources shared by health experts, advocates, and organizations into WisdomCards.
-
OrganizedWisdom MS
Organizing multiple sclerosis resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
